Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper

Front Bioeng Biotechnol. 2023 Nov 6:11:1294266. doi: 10.3389/fbioe.2023.1294266. eCollection 2023.

¹ Laboratory of Bionanotechnology, Microbiology and Virology, Novosibirsk State University, Novosibirsk, Russia.
² State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Russia.
³ Department of Medicinal Chemistry, N.N Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Novosibirsk, Russia.
⁴ Department of Physical-Chemistry Biology and Biotechnology, Altay State University, Barnaul, Russia.
⁵ N.D Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Abstract

[This corrects the article DOI: 10.3389/fbioe.2023.1187761.].

Keywords: 3CL protease; E. coli bacteria; RBD; SARS-CoV-2; TEV protease.